Zyclara®

DRUG2 trials

Sponsors

Teva Pharmaceuticals USA, Actavis Inc.

Conditions

Actinic Keratosis

Phase 3

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

CompletedNCT01686152

Teva Pharmaceuticals USAActinic Keratosis

Start: 2012-09-30End: 2013-08-31Updated: 2020-11-24

A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses

CompletedNCT02120898

Actavis Inc.Actinic Keratosis

Start: 2013-10-10End: 2014-04-30Updated: 2019-12-13